Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~- Subjective complaints of poor near vision that impact activities of daily living~Exclusion Criteria:~* History of cataract surgery, phakic intraocular lens surgery, corneal inlay surgery, radial keratotomy, or any intraocular surgery~* Use of any topical ophthalmic medications, including artificial tears other than the study medications during the study~* Use of temporary or permanent punctal plugs or history of punctal cautery in one or both eyes~* Corneal abnormalities (including keratoconus, corneal scar, Fuchs' endothelial dystrophy, guttata, or edema) in either eye that are likely to interfere with visual acuity~* Narrow iridocorneal angles (Shaffer grade ≤2 or lower on gonioscopy examination), history of angle-closure glaucoma, or previous iridotomy~* Diagnosis of any type of glaucoma or ocular hypertension

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Vehicle (Type: PLACEBO_COMPARATOR): Participants received one drop of vehicle in each eye, once daily, for up to 30 days.
- Pilocarpine HCl Ophthalmic Solution (Type: EXPERIMENTAL): Participants received one drop of pilocarpine HCl ophthalmic solution 1.25% in each eye, once daily, for up to 30 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).